Mingxiang Ye

8.2k total citations
31 papers, 1.1k citations indexed

About

Mingxiang Ye is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingxiang Ye has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingxiang Ye's work include Lung Cancer Treatments and Mutations (7 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Mingxiang Ye is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Mingxiang Ye collaborates with scholars based in China and United States. Mingxiang Ye's co-authors include Tangfeng Lv, Dong Wang, Faxiang Wang, Xinyi Xia, Fang Zhang, Libo Yao, Yi Ren, Dian Fu, Jiän Zhang and Pengyu Jing and has published in prestigious journals such as Biomaterials, Cancer Research and Scientific Reports.

In The Last Decade

Mingxiang Ye

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingxiang Ye China	17	596	266	261	226	117	31	1.1k
Yu Hu China	20	603 1.0×	411 1.5×	211 0.8×	182 0.8×	137 1.2×	58	1.1k
Xiangyang Lin China	17	466 0.8×	256 1.0×	221 0.8×	92 0.4×	64 0.5×	38	915
Xiaojuan Xiao China	19	454 0.8×	120 0.5×	102 0.4×	224 1.0×	84 0.7×	55	1.0k
Srinivas Chava United States	20	614 1.0×	400 1.5×	47 0.2×	154 0.7×	73 0.6×	41	1.2k
Yirong Li China	23	953 1.6×	527 2.0×	113 0.4×	345 1.5×	241 2.1×	49	1.6k
Chenglong Li China	20	668 1.1×	187 0.7×	52 0.2×	152 0.7×	79 0.7×	66	1.1k
Davoud Rostamzadeh Iran	16	420 0.7×	183 0.7×	41 0.2×	149 0.7×	110 0.9×	35	1.0k
Praveenkumar Shetty India	18	496 0.8×	181 0.7×	44 0.2×	122 0.5×	122 1.0×	58	847
Yarong Song China	17	519 0.9×	343 1.3×	133 0.5×	242 1.1×	186 1.6×	42	1.1k
Lise Willems France	16	1.2k 2.1×	224 0.8×	107 0.4×	314 1.4×	118 1.0×	48	1.9k

Countries citing papers authored by Mingxiang Ye

Since Specialization

Citations

This map shows the geographic impact of Mingxiang Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxiang Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxiang Ye more than expected).

Fields of papers citing papers by Mingxiang Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxiang Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxiang Ye. The network helps show where Mingxiang Ye may publish in the future.

Co-authorship network of co-authors of Mingxiang Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxiang Ye. A scholar is included among the top collaborators of Mingxiang Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxiang Ye. Mingxiang Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xinxin, Guoxin Wang, Wei Bao, et al.. (2025). Pathologic complete response to pralsetinib in stage IV RET-positive non-small cell lung cancer: A case report. Respiratory Medicine Case Reports. 54. 102186–102186.

Zhang, Qianqian, et al.. (2025). Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC. Cancer Immunology Immunotherapy. 74(7). 213–213. 1 indexed citations

Chen, Jiayan, Yueyue Song, Yingshui Yao, et al.. (2024). Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism. ACS Applied Materials & Interfaces. 16(42). 56910–56925. 4 indexed citations

Chen, Jiayan, Wanjun Lu, Ping Zhan, et al.. (2024). Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 16. 15 indexed citations

Lv, Tangfeng, Qi Zhao, Jia Liu, et al.. (2024). Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice. Infection. 52(2). 625–636. 11 indexed citations

Zhang, Yong, Yanlu Xiong, Jun Jiang, et al.. (2024). Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study. Frontiers in Genetics. 15. 1293668–1293668. 1 indexed citations

Wang, Zimu, Hairong Huang, Li Wang, et al.. (2024). NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis. Cell Death Discovery. 10(1). 240–240. 15 indexed citations

Wang, Yimin, Hedong Han, Fang Zhang, et al.. (2022). Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis. British Journal of Cancer. 127(5). 948–956. 22 indexed citations

Wang, Zimu, Jiaxin Liu, Hairong Huang, et al.. (2021). Metastasis-associated fibroblasts: an emerging target for metastatic cancer. Biomarker Research. 9(1). 47–47. 42 indexed citations

10.

Liang, Ye, Li Zhou, Xi Chen, et al.. (2021). Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer. OncoTargets and Therapy. Volume 14. 2327–2335. 16 indexed citations

11.

Jing, Pengyu, Nan Zhao, Mingxiang Ye, et al.. (2018). Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling. Cancer Letters. 427. 38–48. 67 indexed citations

12.

Ye, Mingxiang, Yong Zhang, Xinxin Zhang, et al.. (2017). Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer. Cancer Research. 77(13). 3527–3539. 42 indexed citations

13.

Ye, Mingxiang, Yong Zhang, Hongjun Gao, et al.. (2017). Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling. Clinical Cancer Research. 24(5). 1227–1239. 59 indexed citations

14.

Ru, Yi, Qinhao Wang, Xiping Liu, et al.. (2016). The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL. Scientific Reports. 6(1). 28352–28352. 20 indexed citations

15.

Ye, Mingxiang, Xinxin Zhang, Nan Li, et al.. (2016). ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance. Oncotarget. 7(11). 12289–12304. 25 indexed citations

16.

Zhang, Xinxin, Ning Chang, Yong Zhang, et al.. (2016). Bakuchiol Protects Against Acute Lung Injury in Septic Mice. Inflammation. 40(2). 351–359. 32 indexed citations

17.

Wang, Yuan, Jian Zhang, Mingxiang Ye, et al.. (2016). HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth. Oncotarget. 7(17). 23594–23607. 9 indexed citations

18.

Chen, Suning, Xingmei Zhu, Hongyu Qiao, et al.. (2015). Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumor Biology. 37(2). 2321–2331. 36 indexed citations

19.

Wang, Yuan, Jian Zhang, Mingxiang Ye, et al.. (2015). siRNA delivered by EGFR-specific scFv sensitizes EGFR-TKI-resistant human lung cancer cells. Biomaterials. 76. 196–207. 23 indexed citations

20.

Ye, Mingxiang, et al.. (2014). Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer. Cancer Letters. 357(1). 196–205. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact